On Friday, Shares of NCR Corporation (NYSE:NCR), dropped -3.38% to $28.88.
NCR Corporation, declared that OTG Administration LLC has deployed the NCR SelfServ 90 self-checkout solution at its restaurant and retail locations within LaGuardia Airport in New York City. Additional deployments within LaGuardia, in addition to in Newark Liberty International Airport, John F. Kennedy International Airport and Ronald Reagan Washington National Airport are planned for later this year.
OTG is recognized throughout the travel industry for exceptional customer focus and groundbreaking innovation. It is transforming airport environments with a focus on dining, design, technology and ease of interaction for airport travelers.
The rollout will support OTG’s efforts to improve the travelers’ experience as the NCR solution can be used as a free-standing self-checkout kiosk, installed on a countertop or even mounted on a wall and is ideal for ‘grab-and-go’ shopping.
The NCR SelfServ 90 is perfect for airport retailers with many shoppers. Several factors led to OTG’s adoption of the solution, counting software integration, ease of use and value. When searching for a modern system, OTG looked for one that could adapt to its environment. OTG’s key purpose was to reduce queues and to make it as seamless a process as possible during peak hours for passengers purchasing just a few items.
“NCR’s consumer transaction technologies enable us to offer our customers more control over their experience,” said OTG CEO Rick Blatstein. “We continue to introduce technologies that our customers are familiar with, such as self-checkout and mobile payment options like Apple Pay, which allow our crew members to spend more time on hospitality.”
NCR Corporation, a technology company, provides solutions and services that enable businesses to connect, interact, and transact with their customers worldwide. The company operates through four segments: Financial Services, Retail Solutions, Hospitality, and Emerging Industries.
Shares of Transocean Ltd. (NYSE:RIG), declined -3.36% to $16.40, during its last trading session.
Transocean, will report earnings for the three months ended March 31, 2015, on Wednesday, May 6, 2015, following the close of trading on the NYSE.
The company will conduct a teleconference starting at 9:30 a.m. EDT, 3:30 p.m. CEST, on Thursday, May 7, 2015, to talk about the results. Individuals who wish to take part in the teleconference should dial +1 913-312-1376 and refer to confirmation code 3397826 about 10 minutes preceding to the planned start time.
Transocean Ltd., together with its auxiliaries, provides offshore contract drilling services for oil and gas wells worldwide. The company primarily offers deepwater and harsh environment drilling services.
At the end of Friday’s trade, Shares of NXP Semiconductors NV (NASDAQ:NXPI), dwindled -3.30% to $95.33.
NXP Semiconductors, declared that two of its engineers have been nominated for the highly-respected and acclaimed EPO European Inventor Award. Franz Amtmann and Philippe Maugars, together with their teams, have been recognized due to their work in the milestone creation of near field communication (NFC).
The EPO European Inventor Award aims to recognize and reward creativity of inventors the world over, who use their technical, scientific and intellectual skills to make a real contribution to technological progress, economic growth and positively impact people’s daily lives.
Co-invented by NXP (formerly Philips Semiconductors) and Sony in 2002, NFC technology now securely connects hundreds of millions of smartphones, tablets, and other consumer electronics. NFC allows devices to establish communications between other devices and infrastructure, passing data by touching them or putting them very closely together. NXP has led the effort to establish the worldwide adoption of NFC technology, and in 2004 assisted found the NFC Forum, the standards-based organization that now comprises more than 170 member companies.
NXP Semiconductors N.V., a semiconductor company, provides high performance mixed signal and standard product solutions for radio frequency (RF), analog, power administration, interface, security, and digital processing products worldwide.
Finally, Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), ended its last trade with -3.27% loss, and closed at $7.09.
Zogenix, Inc. (ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders, declared recently that it has closed the sale of its Zohydro(R) ER (hydrocodone bitartrate) business to a wholly-owned partner of Pernix Therapeutics Holdings, for $80 million in cash, about 1.68 million shares of Pernix common stock, plus regulatory and sales milestones of up to $283.5 million.
The sale of Zohydro ER to Pernix significantly reduces operating expenses for Zogenix, eliminates all research and development expenses related to ongoing Zohydro ER abuse-deterrent formulations and further enhances the Company’s financial strength. With the upfront proceeds from this transaction, and without assuming future milestone payments related to Zohydro ER, the Company plans to use the capital to fund the current Relday clinical program to the end of Phase 2 meeting with the U.S. Food and Drug Administration, both the US and EU Phase 3 studies for ZX008 and the submission of the New Drug Application for ZX008 targeted for late 2016.
Pernix Therapeutics Holdings, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells branded and generic pharmaceutical products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.